Renalytix AI PLC ADR (RNLX): Price and Financial Metrics
GET POWR RATINGS... FREE!
RNLX Stock Price Chart Interactive Chart >
RNLX Price/Volume Stats
|Current price||$19.80||52-week high||$35.71|
|Prev. close||$18.01||52-week low||$9.91|
|Day high||$19.82||Avg. volume||116,874|
|50-day MA||$26.72||Dividend yield||N/A|
|200-day MA||$25.84||Market Cap||715.08M|
Renalytix AI PLC ADR (RNLX) Company Bio
Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded on March 15,2018 and is headquartered in Penarth, the United Kingdom.
Most Popular Stories View All
RNLX Latest News Stream
|Loading, please wait...|
RNLX Latest Social Stream
View Full RNLX Social Stream
Latest RNLX News From Around the Web
Below are the latest news stories about Renalytix plc that investors may wish to consider to help them evaluate RNLX as an investment opportunity.
Good morning, investor!
Targeted testing run rate of 300 diabetic kidney disease patients per week in calendar Q4 2021NEW YORK and SALT LAKE CITY, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the KidneyIntelX™ early-stage risk assessment testing and care management program across primary care and specialty clinician networks under a real-world evidence development program for patients with diabetic kidney diseas
All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.
NEW YORK and SALT LAKE CITY, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (Renalytix or the Company) today announced the company will be presenting at the upcoming 2021 Wells Fargo Virtual Healthcare Conference.
Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic
RNLX Price Returns